Bioavailability of ASKP1240 in Healthy Subjects After Intravenous and Subcutaneous Administration of ASKP1240

Clinical trial NCT01582399 · COMPLETED

Trial details

NCT number: NCT01582399
Sponsor: Astellas Pharma Global Development, Inc.
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Pharmacokinetics of ASKP1240 Pharmacodynamics of ASKP1240 Healthy Volunteers

Start date: 2012-02-01
Primary completion: 2012-09-01
Enrollment: 24

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.